Emerging roles for the intestinal microbiome in epilepsy

Area of Science:

• Neuroscience
• Microbiology
• Gastroenterology

Background:

• The gut microbiome plays a crucial role in brain function and is implicated in neurological disorders.
• Alterations in gut microbiota composition are observed in epilepsy and following seizure interventions.

Purpose of the Study:

• To review recent findings on the gut microbiome's role in refractory epilepsy.
• To explore how factors like antibiotics, infections, ketogenic diets, probiotics, and anti-epileptic drugs interact with the microbiome to affect seizures.

Main Methods:

• Literature review of recent studies on gut microbiota and epilepsy.
• Analysis of human and animal model data regarding seizure susceptibility and microbiome alterations.
• Evaluation of microbiome-mediated effects of various epilepsy treatments.

Main Results:

• Individuals with refractory epilepsy show distinct gut microbiota compositions.
• Antibiotic treatments and infections can modify seizure susceptibility via microbiome changes.
• The gut microbiome is a potential mediator for the efficacy of ketogenic diets, probiotics, and anti-epileptic drugs in reducing seizure frequency and severity.

Conclusions:

• The gut microbiome is a significant factor in epilepsy pathophysiology and treatment.
• Further research is needed to fully understand the microbiome's role in epilepsy risk and to develop novel therapeutic strategies.
• Targeting the gut microbiome may offer new avenues for treating refractory epilepsy.